Cellex [injection] 5 ampoules 1ml 0.1mg

Regular price $300.00

20% discount is applied when paying with Bitcoin or an ‘altcoin’ such as Etherium, Litecoin, etc.

Cellex is a unique original product in its class

Active ingredients:
Active substance per 1 ml: Cellex® substance-solution calculated with reference to protein 0.100 mg

Active substance:

Polypeptides from embryonic pig brain, calculated with reference to total protein 0.9 – 2.4 mg (label claim of total protein is 1.65 мг per1 ml of the substance).


Cellex is a novel product which consists of the balanced and stable mixture of biologically active proteins and polypeptides with combined multifunctional action. The product activates secondary neuroprotection due to the stimulation of synaptogenesis, autophagy signalling restoration, tissue immune regulation, improvement of tissue immune regulation with inhibition of immunogenic macrophages cytotoxicity. This is accompanied by tissue-specific and systemic reparative action of the product with the restoration of regenerative and reparative potential of brain cells, a decrease of the number of damaged cells and intensity of perifocal edema in the area of penumbra(making possible to achieve a significant limitation of the focus of necrosis of brain tissue) with the restoration of microcirculation and total perfusion.

The restoration and regulatory stimulation of various СNS compartments with systemic action of growth factors, differentiation and signal molecules provides reduction of the recovery period and rehabilitation of patients with lesions of the central and peripheral nervous system of vascular genesis and the restoration of motor, sensory and cognitive functions. The therapeutic effect usually occurs within 3 to 5 days after the beginning of the product administration.

Indications:

  • cerebrovascular diseases
  • acute cerebrovascular accidents - during the acute and early rehabilitation period of the disease as part of a comprehensive therapy



Active ingredient per 1 ml:
Cellex® substance-solution (frozen calculated with reference to protein* 0.100 mg

Excipients:
Glycine 3.75 mg
Disodium hydrogen phosphate dehydrate 2.99 mg
Sodium dihydrogen phosphate monohydrate 0.47 mg
Sodium chloride 5.85 mg
Water for injections up to 1.0 ml
* - Active ingredient per 1 ml:

Active substance:
Polypeptides from embryonic pig brain, calculated with reference to total protein 0.9 – 2.4 mg (label claim of total protein is 1.65 мг per1 ml of the substance).

Excipients:
Glycine 3.75 mg, 0.1М solution of Disodium hydrogen phosphate up to рН 7.8 (approximately 0.8 mg of dry substance), Sodium chloride 5.85 mg, Polysorbate-80 0.005 mg, water filtered up to 1 ml.

Description: Clear colorless or light yellow liquid, odorless or with characteristic odor. Opalescence is permissible. Occasional coagulate fibers are permissible.

Mode of administration: the product is injected subcutaneously through the sterile syringe filter supplied in the kit. The syringe is filled with the quantity of Cellex® necessary for the injection, then it is necessary to take off the needle, attach a sterile syringe filter with pore diameter 0.22 µm. A new needle is attached to the sterile syringe filter. The preparation is ready for use.

Pharmacotherapeutic class:
Nootropic medication, other medications influencing the nervous system.

ATC-code: N06BX, N07XX

Pharmacology
Pharmacodynamics:
The presence of tissue-specific signaling proteins and polypeptides - growth factors, differentiating factors of nerve cells in the product provides its direct neuroreparative action due to the regulation of neurotransmitter pool concentration, with the inhibition of spillover of excitatoty aminoacids.

The product activates secondary neuroprotection due to the stimulation of synaptogenesis, autophagy signalling restoration, improvement of tissue immune regulation with inhibition of immunogenic macrophages cytotoxicity. This is accompanied by tissue-specific and systemic reparative action of the product with the restoration of regenerative and reparative potential of brain cells, a decrease of the number of damaged cells and intensity of perifocal edema in the area of penumbra(making possible to achieve a significant limitation of the focus of necrosis of brain tissue) with the restoration of micricirculation and total perfusion.

The restoration and regulatory stimulation of various СNS compartments with systemic action of growth factors, differentiation and signal molecules provides reduction of the recovery period and rehabilitation of patients with lesions of the central and peripheral nervous system of vascular genesis and the restoration of motor, sensory and cognitive functions.

The therapeutic effect usually occurs within 3 to 5 days after the beginning of the product administration.

Pharmacokinetics:
Complex composition of Cellex® with the active fraction consisting of the balanced and stable mixture of biologically active proteins and polypeptides with combined multifunctional action makes it impossible to carry out pharmacokinetic analysis of separate constituents.


Indications
cerebrovascular diseases
acute cerebrovascular accidents - during the acute and early rehabilitation period of the disease as part of comprehensive therapy
Contraindications
Epilepsy, manic illness, delusions, delirium, not for children under the age of 18 (not enough clinical safety data).

Mode of administration and dosage
For adults the product is prescribed in a dose of 0.1 – 0.2 mg once a day subcutaneously during10 days depending on the severity of the condition. If necessary the course of treatment is repeated in 10 days. The studies on the safety of the use in children haven't been carried out.

Warnings and precautions for use
Should be prescribed with care to patients with a history of hypersensitivity reaction to protein and peptide medications.

Overdosage
No cases of overdosage of Cellex® have been reported at present.

Side effects
Hypersensitivity reactions in the form of mild hyperemia at the injection site, skin rash, itching, angioneurotic edema, sleep disturbance, headache.

Interaction with other medicines
Concomitant administration with psychoactivators and alcoholic drinks may cause psychomotor agitation and sleep disturbance.

The product may reduce the activity of anesthetic agents, tranquilizers and neuroleptic agents.

Administration during pregnancy and lactation period
The use of the product during pregnancy and lactation period has not been studied. Not for use in such patients.

Influence on the ability to drive and operate machinery
At present no data exist on the effects of Cellex® on the ability to drive and operat

Storage conditions
Protect from light. Store at a temperature of 2° - 8°С. Keep out of reach of children.

Shelf life
1 year.

Do not use after expiration date.

Please research the uses of this product before completing your purchase. Customer satisfaction is our number one priority, if you are not 100% satisfied with the product you received please contact us at sale@brainlabz.ru